hSTC810

· STCube, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hSTC810, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of hSTC810 in Combination With Paclitaxel in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer [Phase 1, Phase 2]

See pricing